التفاصيل البيبلوغرافية
| العنوان: |
What Is the Antibody Response and Role in Conferring Natural Immunity After SARS-CoV-2 Infection? Rapid, Living Practice Points From the American College of Physicians (Version 1). |
| المؤلفون: |
Qaseem, Amir, Yost, Jennifer, Etxeandia-Ikobaltzeta, Itziar, Forciea, Mary Ann, Abraham, George M., Miller, Matthew C., Obley, Adam J., Humphrey, Linda L., Scientific Medical Policy Committee of the American College of Physician |
| المصدر: |
Annals of Internal Medicine; 6/15/2021, Vol. 174 Issue 6, p828-835, 8p, 1 Diagram, 4 Charts |
| مصطلحات موضوعية: |
NATURAL immunity, SARS-CoV-2, ANTIBODY formation, PHYSICIANS, MEDICAL personnel |
| الشركة/الكيان: |
UNITED States. Agency for Healthcare Research & Quality |
| مستخلص: |
Description: The widespread availability of SARS-CoV-2 antibody tests raises important questions for clinicians, patients, and public health professionals related to the appropriate use and interpretation of these tests. The Scientific Medical Policy Committee (SMPC) of the American College of Physicians developed these rapid, living practice points to summarize the current and best available evidence on the antibody response to SARS-CoV-2 infection, antibody durability after initial infection with SARS-CoV-2, and antibody protection against reinfection with SARS-CoV-2.Methods: The SMPC developed these rapid, living practice points based on a rapid and living systematic evidence review done by the Portland VA Research Foundation and funded by the Agency for Healthcare Research and Quality. Ongoing literature surveillance is planned through December 2021. When new studies are identified and a full update of the evidence review is published, the SMPC will assess the new evidence and any effect on the practice points.Practice Point1: Do not use SARS-CoV-2 antibody tests for the diagnosis of SARS-CoV-2 infection.Practice Point2: Antibody tests can be useful for the purpose of estimating community prevalence of SARS-CoV-2 infection.Practice Point3: Current evidence is uncertain to predict presence, level, or durability of natural immunity conferred by SARS-CoV-2 antibodies against reinfection (after SARS-CoV-2 infection). [ABSTRACT FROM AUTHOR] |
|
Copyright of Annals of Internal Medicine is the property of American College of Physicians and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Complementary Index |
